For instance, neutrophils have been proposed to play a regulatory role in psoriatic inflammation via the release of elastase and the consequent activation of the anti-inflammatory cytokine IL-36 receptor antagonist (58), a negative modulator of psoriasis development (58). This evidence concerns the gene IL1RL2 and psoriasis.